Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

FDA names second participant in TEMPO digital health pilot

17 August 2026 · By · Wire by Fusion42

Published

17 August 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 17 August 2026 · Fusion42 review

The FDA has added Cadence, an AI-enabled hypertension management software company, as the second participant in its TEMPO digital health pilot, allowing participants to collect real-world data through Medicare.

This Wire brief sits within Fusion42's coverage of Digital Health, and 2 sources have reported it.

◆ ◆ The Wire takeaway

You can now access new US real-world data routes through Medicare by joining FDA digital health pilots like TEMPO. This changes how you validate and scale AI health software under regulatory oversight.

◆ Coverage

2 sources · 17 Aug 2026

◆ Related on Wire

◆ Topics

Digital HealthFDAdigital-healthpilot-programreal-world-datamedicare